文献速递血栓与止血

遗传性出血性毛细血管扩张症出血的患病率及危险因素:全国住院患者样本研究

Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study.
PubMed 文献 · Blood Adv · 2023-01-01

基于美国全国住院患者样本(NIS)2016-2018年成人出院记录,共18 170 849例出院中2528例(0.01%)患遗传性出血性毛细血管扩张症(HHT),其中648例(25.6%)发生出血。HHT患者动静脉畸形、血管发育不良、毛细血管扩张和鼻出血比例高于非HHT患者,而月经过多和产后出血比例低于非HHT患者。多变量logistic回归显示消化性溃疡病、门静脉血栓和丙型肝炎与HHT出血显著相关。

要点

  • HHT住院患者中出血发生率为25.6%,动静脉畸形和血管发育不良较非HHT更常见。
  • 缺铁性贫血在伴或不伴出血的HHT患者中同样常见(15.7% vs 16.0%),提示持续失血并需普遍铁筛查。
  • 消化性溃疡病(OR 8.86)、门静脉血栓(OR 3.68)和丙型肝炎(OR 2.13)与HHT出血显著相关。

核心结论

  • HHT患者中动静脉畸形和血管发育不良较非HHT更常见,而月经过多和产后出血较非HHT更少见。
  • 缺铁性贫血在伴或不伴出血的HHT患者中同样常见,提示持续失血并需普遍铁筛查。

研究设计与样本

  • 基于美国全国住院患者样本(NIS)2016-2018年成人出院记录的回顾性研究,共纳入18 170 849例出院,其中2528例(0.01%)患HHT。
  • 采用NIS出院层面权重进行患病率加权估计,并通过加权多变量logistic回归分析出血的危险因素。

主要发现

  • 在2528例HHT患者中,648例(25.6%)发生出血。
  • HHT患者较非HHT患者更常见动静脉畸形(31.9% vs 1.3%)、血管发育不良(23.5% vs 2.3%)、毛细血管扩张(2.3% vs 0.2%)和鼻出血(17.9% vs 0.6%),各P < .001。
  • 育龄期HHT患者较非HHT患者月经过多和产后出血更少见,各P < .001。
  • 缺铁性贫血在伴出血与不伴出血的HHT患者中同样常见(15.7% vs 16.0%),但高于非HHT患者(7.5%),P < .001。
  • HHT患者较非HHT患者更常见胃食管反流(25.9% vs 20.0%)和肝硬化(10.0% vs 3.6%),各P < .001。

关键数值与推荐

  • 多变量logistic回归显示,消化性溃疡病(OR 8.86;P < .001)、门静脉血栓(OR 3.68;P = .006)和丙型肝炎(OR 2.13;P = .017)与HHT出血显著相关。

临床怎么用

  • 原文结论提示HHT患者需普遍进行铁筛查,原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hereditary hemorrhagic telangiectasia (HHT) is a common bleeding disorder, but little is known regarding prevalence and risk factors for bleeding. Adult discharges with HHT and bleeding were identified by International Classification of Disease, 10th edition (ICD-10) codes in the National Inpatient Sample (NIS), 2016-2018. Prevalence estimates were weighted using NIS discharge-level weights to reflect national estimates. Risk factors for bleeding were determined by weighted multivariable logistic regression. Among 18 170 849 discharges, 2528 (0.01%) had HHT, of whom 648 (25.6%) had bleeding. Arteriovenous malformation (AVM) (31.9% vs 1.3%), angiodysplasia (23.5% vs 2.3%), telangiectasia (2.3% vs 0.2%), and epistaxis (17.9% vs 0.6%) were more common in HHT than in non-HHT patients (non-HHT), each P < .001. In contrast, menstrual (HMB) and postpartum bleeding (PPH) were less common in reproductive-age HHT than non-HHT, each P < .001. Anemia associated with iron deficiency (IDA), was equally common in HHT with or without bleeding (15.7% vs 16.0%), but more common than in non-HHT (7.5%), P < .001. Comorbidities, including gastroesophageal reflux (25.9% vs 20.0%) and cirrhosis (10.0% vs 3.6%) were greater in HHT than non-HHT, each P < .001. In multivariable logistic regression, peptic ulcer disease (OR, 8.86; P < .001), portal vein thrombosis (OR, 3.68; P = .006), and hepatitis C, (OR, 2.13; P = .017) were significantly associated with bleeding in HHT. In conclusion, AVM and angiodysplasia are more common and HMB and PPH less common in patients in those with HHT than non-HHT. IDA deficiency is as common in HHT with and without bleeding, suggesting ongoing blood loss and need for universal iron screening.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zarka J, Jeong K, Yabes JG, et al. Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study. Blood Adv. 2023. PMID: 37567149. doi:10.1182/bloodadvances.2023010743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。